These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21515841)

  • 1. Impact of intranasal insulin on insulin antibody affinity and isotypes in young children with HLA-conferred susceptibility to type 1 diabetes.
    Ryhänen SJ; Härkönen T; Siljander H; Näntö-Salonen K; Simell T; Hyöty H; Ilonen J; Veijola R; Simell O; Knip M
    Diabetes Care; 2011 Jun; 34(6):1383-8. PubMed ID: 21515841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.
    Hoppu S; Härkönen T; Ronkainen MS; Simell S; Hekkala A; Toivonen A; Ilonen J; Simell O; Knip M
    Clin Exp Immunol; 2006 Apr; 144(1):59-66. PubMed ID: 16542366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.
    Näntö-Salonen K; Kupila A; Simell S; Siljander H; Salonsaari T; Hekkala A; Korhonen S; Erkkola R; Sipilä JI; Haavisto L; Siltala M; Tuominen J; Hakalax J; Hyöty H; Ilonen J; Veijola R; Simell T; Knip M; Simell O
    Lancet; 2008 Nov; 372(9651):1746-55. PubMed ID: 18814906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
    Mäkinen A; Härkönen T; Ilonen J; Knip M;
    Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.
    Siljander H; Härkönen T; Hermann R; Simell S; Hekkala A; Salonsaari RT; Simell T; Simell O; Ilonen J; Veijola R; Knip M
    Diabetes Metab Res Rev; 2009 Oct; 25(7):615-22. PubMed ID: 19637309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes.
    Hoppu S; Ronkainen MS; Kimpimäki T; Simell S; Korhonen S; Ilonen J; Simell O; Knip M
    Pediatr Res; 2004 Feb; 55(2):236-42. PubMed ID: 14605243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes.
    Harrison LC; Honeyman MC; Steele CE; Stone NL; Sarugeri E; Bonifacio E; Couper JJ; Colman PG
    Diabetes Care; 2004 Oct; 27(10):2348-55. PubMed ID: 15451899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood.
    Luopajärvi K; Savilahti E; Virtanen SM; Ilonen J; Knip M; Akerblom HK; Vaarala O
    Pediatr Diabetes; 2008 Oct; 9(5):434-41. PubMed ID: 18503496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
    Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies.
    Kikuoka N; Sugihara S; Yanagawa T; Ikezaki A; Kim HS; Matsuoka H; Kobayashi Y; Wataki K; Konda S; Sato H; Miyamoto S; Sasaki N; Sakamaki T; Niimi H; Murata M
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):597-603. PubMed ID: 11894970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.
    Siljander HT; Simell S; Hekkala A; Lähde J; Simell T; Vähäsalo P; Veijola R; Ilonen J; Simell O; Knip M
    Diabetes; 2009 Dec; 58(12):2835-42. PubMed ID: 19755526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
    Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
    Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
    Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
    Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rs11203203 is associated with type 1 diabetes risk in population pre-screened for high-risk HLA-DR,DQ genotypes.
    Johnson K; Wong R; Barriga KJ; Klingensmith G; Ziegler AG; Rewers MJ; Steck AK
    Pediatr Diabetes; 2012 Dec; 13(8):611-5. PubMed ID: 22776074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.
    Keskinen P; Korhonen S; Kupila A; Veijola R; Erkkilä S; Savolainen H; Arvilommi P; Simell T; Ilonen J; Knip M; Simell O
    Diabetologia; 2002 Dec; 45(12):1639-48. PubMed ID: 12488953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
    Kukko M; Kimpimäki T; Korhonen S; Kupila A; Simell S; Veijola R; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2005 May; 90(5):2712-7. PubMed ID: 15872335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.